Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.34 | N/A |
| PEG Ratio (TTM) | -0.32 | N/A |
| P/S Ratio (TTM) | 0.44 | N/A |
| P/B Ratio (TTM) | 0.25 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 2.89 | N/A |
| Price to 5YR AVG FCF Ratio | 1.20 | N/A |
Profitability (28%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.08% | N/A |
| ROE (TTM) | 1.47% | N/A |
| Net Profit Margin (TTM) | 2.39% | N/A |
| ROIC 5YR AVG | 0.09% | N/A |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.96% | -267.97% | -149.44% |
| Revenue | 0.53% | 43.24% | 24.63% |
| Net Income | -7.29% | -208.00% | -113.49% |
| Cash Flow | N/A | -4.46% | -25.47% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.91 | N/A |
| Quick Ratio (TTM) | 2.67 | N/A |
| D/E Ratio (TTM) | 0.04 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.83 | N/A |
| LTL to 5YR AVG FCF | 1.16 | N/A |
| Shares Outstanding Growth 5YR AVG | 36.63% | N/A |